Mark N. Wegman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 7,800 shares at $61.09 ($477K) on 2019-05-24, disclosed to the SEC on 2019-05-28.
Open-market sale of $477k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BSTC | SELL | 2018-09-11 | $374K | — | Filing → |
| BSTC | SELL | 2018-08-23 | $895K | — | Filing → |